
On December 5, Senators Warren and Grassley sent a letter to the Acting FDA Commissioner, Brett Giroir, MD, pointing out the fact that the FDA previously announced that over-the-counter (OTC) hearing aid rules would be a priority on their fall 2018 Unified Agenda and they would likely deliver the proposed rules well in advance of the August 2020 statutory deadline. Senators Warren and Grassley note that “it is now December 2019 and we have yet to see these regulations come to fruition.”
Citing the serious nature of hearing difficulties and the related conditions that frequently accompany them, the letter requests that the FDA provide an update on the status of the OTC hearing aid rules and regulations and when the FDA expects to finalize the OTC hearing aid rules no later than December 19, 2019.
Recent Posts
Senate Passes Continuing Resolution: What It Means for Hearing Health
The Senate recently passed a continuing resolution (CR) to keep the federal government funded through December 11, 2026, giving Congress additional time to complete the…
General Audiology Board Certification (GABC): Historical, Current and Future Perspectives and Why It Matters
Like many other healthcare professionals, audiologists have the dubious distinction of the “alphabet signature” indicating our training and education, our expertise, and commitment to our…



